Aptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations. The company operates through four divisions: Aptus Pharma, Pioneer division which includes marketing of acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs; Aptus CD Care, Cardiac Diabetic division which includes marketing of chronic therapies, including anti-hypertensive, anti-diabetic, and lipid-lowering; Aptus Wellcare offers wellness and nutraceutical products, over-the-counter (OTC) formulations, and personal care products; and Aptus Global, export division engages in exploring and developing opportunities in overseas markets, semi-regulated and emerging countries. It also offers anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products. Its products are available in balms, capsules, drops, gels, injections, lotions, ointments, powders, sachets, softgels, solutions, suspensions, syrups, tablets, and vials. It distributes the products through clearing and forwarding agents. Aptus Pharma Limited was incorporated in 2010 and is headquartered in Rajkot, India.
Metrics to compare | APTM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAPTMPeersSector | |
---|---|---|---|---|
P/E Ratio | 19.9x | 39.8x | −0.7x | |
PEG Ratio | 1.79 | 0.21 | 0.00 | |
Price/Book | - | 3.0x | 2.6x | |
Price / LTM Sales | 2.5x | 3.8x | 3.4x | |
Upside (Analyst Target) | - | 4.1% | 37.9% | |
Fair Value Upside | Unlock | −10.6% | 5.2% | Unlock |